-
Immunogenicity to SARS-CoV-2 Omicron variant among school-aged children with 2-dose of inactivated SARS-CoV-2 vaccines followed by BNT162b2 booster
- Back
Metadata
Document Title
Immunogenicity to SARS-CoV-2 Omicron variant among school-aged children with 2-dose of inactivated SARS-CoV-2 vaccines followed by BNT162b2 booster
Author
Chantasrisawad N, Puthanakit T, Kornsitthikul K, Jaru-Ampornpan P, Tawan M, Matapituk P, Sophonphan J, Anugulruengkitt S, Tangsathapornpong A, Katanyutanon A, Team KSTKS
Name from Authors Collection
Scopus Author ID
57277333600
Scopus Author ID
8071686900
Scopus Author ID
55199829700
Scopus Author ID
7186590500
Affiliations
Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Thammasat University; Ministry of Public Health - Thailand
Type
Article
Source Title
VACCINE: X
Year
2022
Volume
12
Open Access
gold, Green Published
Publisher
ELSEVIER
DOI
10.1016/j.jvacx.2022.100221
Format
Abstract
Background: A primary series of 2-dose SARS-CoV-2 vaccines based on an ancestral strain generate inad-equate neutralizing antibodies against the SARS-CoV-2 Omicron variant. This study aimed to describe the immune response from giving healthy school-aged children who previously received 2 inactivated vac-cines an mRNA BNT162b2 booster.Methods: Healthy children aged 5-11 years who received 2 doses of CoronaVac or Covilo were enrolled and received 10 lg BNT162b2 intramuscularly. Neutralizing antibody against Omicron variant was mea-sured at pre-booster and 14-21 days post-booster by surrogate virus neutralization test (sVNT, %inhibi-tion) and pseudovirus neutralization test (pVNT, ID50). Antibody responses were compared with a parallel cohort of children who received 2 doses of BNT162b2 3 weeks apart.Results: From April to May 2022, 59 children with a mean age (SD) of 8.5 years (1.7) were enrolled: 20 CoronaVac and 39 Covilo recipients. The median interval from the primary series was 49 days (IQR 33-51). After booster, the geometric means (GMs) of sVNT and pVNT were 72.2 %inhibition (95 %CI 67.2-77.6) and 499 (95 %CI 399-624), respectively. The proportion of children with sVNT against Omicron strain >= 68 %inhibition increased from none to 70.2 %. The geometric mean ratio (GMR) of sVNT and pVNT compared with a parallel cohort were 4.3 and 12.2, respectively. The GMR of sVNT and pVNT between children who received booster dose at >6-week interval were 1.2 (95 %CI 1.1-1.3). and 1.8 (95 %CI 1.2-2.7) compared with 4-6 weeks interval.Conclusion: A regimen of 2-dose of inactivated vaccine followed by BNT162b2 booster dose elicited high neutralizing antibody against the Omicron variants in healthy school-aged children.(c) 2022 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Funding Sponsor
National Vaccine Institute; Depart-ment of Diseases Control, Ministry of Public Health, Thailand; [2565.1/5]
License
CC BY-NC-ND
Rights
Authors
Publication Source
WOS